A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
Public ClinicalTrials.gov record NCT00004580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase I/II Study of ABT-378/Ritonavir in Protease Inhibitor Experienced HIV-Infected Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if it is safe and effective to give ABT-378/ritonavir combination plus nevirapine plus two nucleoside transcriptase inhibitors to HIV-infected patients who previously have taken protease inhibitors. This study also examines how the body handles this combination of anti-HIV drugs.
Study identification
- NCT ID
- NCT00004580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Feb 19, 2009
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Oaks Research | Beverly Hills | California | 90211 | — |
| San Francisco Gen Hosp / UCSF AIDS Program | San Francisco | California | 94110 | — |
| Univ of Colorado Health Sciences Ctr | Denver | Colorado | 80262 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Rush Presbyterian St Lukes Med Ctr / Sect Infect Dise | Chicago | Illinois | 60612 | — |
| Univ North Carolina at Chapel Hill / Dept of Medicine | Chapel Hill | North Carolina | 27599 | — |
| Duke Univ Med Ctr / Infectious Disease Clinic | Durham | North Carolina | 27710 | — |
| Univ of Cincinnati Med Ctr / Holmes Div Mail Loc 0405 | Cincinnati | Ohio | 452670405 | — |
| Univ of Pittsburgh | Pittsburgh | Pennsylvania | 152132582 | — |
| Infectious Disease Physicians Inc | Annandale | Virginia | 22203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00004580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2009 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00004580 live on ClinicalTrials.gov.